TTR and hereditary amyloidosis: The genetic testing of proband’s relatives and the adoption of good practices to monitor even subtle clinical changes in asymptomatic carriers are particularly relevant for familial amyloidosis of TTR-type given the recent availability of effective innovative treatments [26].